The odds ratio (OR) for early-onset breast cancer in our RVCL patients is 8.74, compared to OR values of 18.8 and 9.3 for BRCA1 and BRCA2 variant carriers, respectively (Fig. 9d)62. This evidence concerns the gene BRCA2 and breast cancer.